Psychedelics
Ketamine Therapy Rapidly Reduces Suicidal Ideation, Study Finds
Patients hospitalized for severe suicidal ideation could benefit from ketamine transfusions, according to new research led by scientists at the University of Montpellier.
Fish on Acid? Microdosing Zebrafish With LSD Shows Its Potential Benefits for Humans
Trevor James Hamilton, an associate professor in neuroscience at MacEwan University, discusses his research into how LSD affects zebrafish – and the implications it could have for mental health treatment.
The Rise of Sponsored Psychedelic Studies Could Bias Research, Warn Psychiatrists
The field of psychedelic drug research is experiencing a renaissance. But this could come at a cost of scientific integrity, argue some researchers.
Antidepressant Psychedelics Could Be Separated From Hallucinations, Suggest Researchers
Researchers have found potentially non-hallucinatory psychedelic compounds by examining crystal structures.
Ketamine and Psilocybin Could Boost the “Integration of New Experiences” By Stimulating Nerves in the Brain
Research from Alex Kwan’s lab has suggested that dendritic plasticity may help support the idea that ketamine and psilocybin can help individuals adopt new perspectives and better process new experiences.
MDMA and Psilocybin Use Linked to Lower Odds of Suicidal Thoughts, Survey Finds
Lifetime use of MDMA is linked to fewer suicidal thoughts, according to the US survey study.
Ketamine Therapy Helps Promote Alcohol Abstinence, Trial Finds
The alcohol-use disorder trial, run by Awakn Life Sciences, has reported its first findings, and it seems like ketamine is a promising treatment.
Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
What Is the Best Approach to Psychedelic Therapy? An Interview With Field Trip’s Ronan Levy
Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.
